Research & News Articles
Contact us if you'd like a copy of any of these articles...
Borrego ME, Short J, House N, et al. New Mexico pharmacists' knowledge, attitudes, and beliefs toward prescribing oral emergency contraception. J Am Pharm Assoc. 2006;46(1):33-43. Available at: https://pubmed.ncbi.nlm.nih.gov/16529339/
DiPietro Mager NA. Fulfilling an unmet need: roles for clinical pharmacists in preconception care. Pharmacotherapy. 2016;36(2):141-151. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26846305
DiPietro NA, Bright DR. Medication therapy management and preconception care: opportunities for pharmacist intervention. Innovations in Pharmacy. 2014;5(1):1-9. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27838391
El-Ibiary SY, Raney EC, Moos MK. The pharmacist’s role in promoting preconception health. J Am Pharm Assoc. 2014;54(5):e288-e303. Available at: https://www.ncbi.nlm.nih.gov/pubmed/25107285
Herman A, McCauley G, Thaxton L, Borrego M, Sussman AL, Espey E. Perspectives on prescribing hormonal contraception among rural New Mexican pharmacists. J Am Pharm Assoc. 2020;Epub. Available at: https://www.ncbi.nlm.nih.gov/pubmed/32249171
Hilverding AT, DiPietro NA. Pharmacists’ attitudes regarding provision of sexual and reproductive health services. J Am Pharm Assoc. 2017;57(40): 493-497. Available at: https://www.ncbi.nlm.nih.gov/pubmed/28619391
Hohmann N, Kavookjian J. Using the Theory of Planned Behavior to determine pharmacy students’ intention to participate in hormonal contraception counseling services. Curr Pharm Teach Learn . 2018;10(11):1488-1495. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30514539
Landau S, Besinque K, Chung F, et al. Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States. J Am Pharm Assoc 2009;49(1):43-50. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19196596
Lio I, Remines J, Nadpara PA, et al. Pharmacists’ comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy. J Am Pharm Assoc. 2018;58:S89-S93. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30006191
McIntosh J, Rafie S, Wasik M, McBane S, Lodise NM, El-Ibiary SY, et al. Changing oral contraceptives from prescription to over-the-counter status: An opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2011;31(4):424-37. Available at: https://www.ncbi.nlm.nih.gov/pubmed/21449630
Miracle DK, Oh GY, Singleton M, Kebodeaux CD, Fink JL III, Freeman PR. Kentucky pharmacists’ perceptions regarding provision of hormonal contraception. J Am Pharm Assoc. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34366288/
Mospan CM, Balenger SB, Gillette C. Student pharmacists' perceptions regarding pharmacist-prescribed hormonal contraceptives and their professional responsibility. J Am Pharm Assoc. 2020;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/33359118/
Newlon JL, Ades R, Vernon V, et al. Pharmacists' Perceptions, Barriers, and Potential Solutions to Implementing a Direct Pharmacy Access Policy in Indiana. Med Care Res Rev. 2021. Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/33016218/
Ng C, Najjar R, DiPietro Mager N, Rafie S. Pharmacist and student pharmacist perspectives on providing preconception care in the United States. J Am Pharm Assoc. 2018. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29884475
Papineau JH, Newlon JL, Ades RS, et al. Evaluation of Student Pharmacists' Attitudes and Perceptions of Hormonal Contraception Prescribing in Indiana. Pharmacy 2021;9(4):185. Available at: https://pubmed.ncbi.nlm.nih.gov/34842821/
Parry RA, Seamon G, Scott MA, Tak CR. North Carolina pharmacists' support for hormonal contraception prescription status change. J Pharm Pract. 2022;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/35325584/
Rafie S, Cieri-Hutcherson NE, Frame TR, et al. Pharmacists' perspectives on prescribing and expanding access to hormonal contraception in pharmacies in the United States. J Pharm Pract 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31390938
Rafie S, McIntosh J, Shealy KM, et al. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy 2014;34(9):991-9. Available at: https://www.ncbi.nlm.nih.gov/pubmed/24989020
Rafie S, Richards E, Rafie S, Landau SC, Wilkinson TA. Pharmacist outlooks on prescribing hormonal contraception following statewide scope of practice expansion. Pharmacy 2019;7(3). Available at: https://www.mdpi.com/2226-4787/7/3/96
Rafie S, Stone RH, Wilkinson TA, Borgelt LM, El-Ibiary SY, Ragland D. Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects. Integr Pharm Res Pract. 2017;6:99-108. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29354556
Rikard R, Elliott J, Dalton E, Stone RH. Pharmacist-prescribed hormonal contraception: does didactic hormonal contraception education affect student pharmacist perceptions of this professional activity? Pharmacy (Basel). 2021;9(3):145. Available at: https://pubmed.ncbi.nlm.nih.gov/34449736/
Rodriguez MI, Herman AM, Espey E, et al. Pharmacists' perspectives and experience prescribing hormonal contraception in rural and urban New Mexico. J Am Pharm Assoc. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/33446459/
Rodriguez MI, McConnell KJ, Swartz J, Edelman AB. Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision. J Am Pharm Assoc 2016;56(5):521-6. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27594105
Seamon GJ, Burke A, Tak CR, et al. Role of pharmacists in hormonal contraceptive access: a survey of North Carolina pharmacists. Pharmacy. 2020;8(4):191. Available at: https://pubmed.ncbi.nlm.nih.gov/33081094/
Vu K, Rafie S, Grindlay K, Gutierrez H, Grossman D. Pharmacist intentions to prescribe hormonal contraception following new legislative authority in California. J Pharm Pract. 2019;32(1):54-61. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29096570
Wollum A, Zuniga C, Katcher T, Daftary M, Grindlay K. Pharmacists' perspectives on prescribing hormonal contraception in Washington, DC, with a focus on young people. J Am Pharm Assoc. 2020;60(4):589-97. Available at: https://pubmed.ncbi.nlm.nih.gov/31953116/
Yous T, Allemann S, Lutters M. Extended access to hormonal contraception in pharmacies: a survey among Swiss pharmacists. Pharmacy. 2020;8(4):210. Available at: https://pubmed.ncbi.nlm.nih.gov/33182547/
Gomez AM, Bennett AH, Schulte A, Arcara J, Stern L, Aina AD, Bardwell J, Cadena D, Chaudhri A, Davis L, et al. Use of preferred source of contraception among users of the pill, patch, and ring in the US. Journal of the American Medical Association Network OPEN. 2024;7(10):e2439191. Available at: https://pubmed.ncbi.nlm.nih.gov/39432309/
Gomez AM, Rafie S, Garner-Ford E, et al. Community perspectives on pharmacist-prescribed hormonal contraception in rural California. Contraception. 2022;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/35671841/
Grossman D, Grindlay K, Li R, Potter JE, et al. Interest in over-the-counter access to oral contraceptives among women in the United States. Contraception. 2013;88(4):544-52. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23664627
Irwin AN, Stewart OC, Nguyen VQ, Bzowyckyj AS. Public perception of pharmacist-prescribed self-administered non-emergency hormonal contraception: An analysis of online social discourse. Res Social Ads Pharm. 2019;15(6):650-5. Available at: https://pubmed.ncbi.nlm.nih.gov/31953116/
Landau SC, Tapias MP, McGhee B. Birth control within reach: a national survey on women's attitudes toward and interest in pharmacy access to hormonal contraception. Contraception 2006;74(6):463-70. Available at: https://www.ncbi.nlm.nih.gov/pubmed/17157103
Lynch S, Garton C, Fiscus J, Kovnat S, Woznicki C, Ali H, Cosler LE. Pharmacist prescribed hormonal contraceptives in New York State: Is there a need and an interest? Journal of the American Pharmacists Association. 2023;63:1607-1611. Available at: https://pubmed.ncbi.nlm.nih.gov/37295493/
Meredith AH, Olenik NL, Farris KB, et al. Women’s perceptions of pharmacist-prescribed hormonal contraception. J Am Coll Clin Pharm. 2020;3(2):425-32. Available at: https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jac5.1169
Meredith AH, Vahary EB, Wilkinson TA, Meagher CG, Vielott T, Ott MA. Adolescents' perceptions of contraception access through pharmacies. Pharmacy 2020;8(2):53. Available at: https://www.ncbi.nlm.nih.gov/pubmed/32231073
O'Connell MB, Samman L, Bailey T, King L, Wellman GS. Attitudes of Michigan female college students about pharmacists prescribing birth control in a community pharmacy. Pharmacy. 2020;8(2):99. Available at: https://pubmed.ncbi.nlm.nih.gov/32526878/
Rafie S, Haycock M, Yen S, Harper CC. Direct pharmacy access to hormonal contraception: California physician and advanced practice clinician views. Contraception. 2012;86(6):687-93. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22717185
Rafie S, Kelly S, Gray EK, et al. Provider opinions regarding expanding access to hormonal contraception in pharmacies. Womens Health Issues. 2016;26(2):153-60. Available at: https://www.ncbi.nlm.nih.gov/pubmed/26549241
Walker T, Colayco D, Yacobi R, et al. Factors associated with unintended pregnancy, contraceptive risk-taking, and interest in pharmacist-provided birth control. J Contemp Pharm Pract. 2020;66(2):17-26. Available at: https://meridian.allenpress.com/jcphp/article/66/2/17/430593/Factors-Associated-with-Unintended-Pregnancy
Wilkinson TA, Miller C, Rafie S, Laudau SC. Older teen attitudes toward birth control access in pharmacies: a qualitative study. Contraception. 2018;97(3):249-255. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29223497
Zuniga C, Wollum A, Katcher T, Grindlay K. Youth perspectives on pharmacists' provision of birth control: findings from a focus group study. J Adolesc Health. 2019;65(4):514-9. Available at: https://pubmed.ncbi.nlm.nih.gov/31326247/
Anderson L, Borgelt LM, Clark P, Moore G. Encouraging comprehensive and consistent pharmacist education for provision of contraception. J Am Pharm Assoc. 2018;58(1):113-116. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29290339
Failla B, Vest K, Lynch S, et al. Impact of a hormonal contraceptive training program for pharmacists. J Am Pharm Assoc. 2022;S1544-3191(22)00065-6. Available at: https://pubmed.ncbi.nlm.nih.gov/35314119/
Harris E, Melody K, Charneski L. Student knowledge and confidence with prescribing hormonal contraception. Curr Pharm Teach Learn. 2020;12(6):751-62. Available at: https://pubmed.ncbi.nlm.nih.gov/32482280/
Lynch SE, Griffin B, Stewart-Lynch A, Vest KM. Effect of a simulated activity on student ability, preparedness, and confidence in applying the pharmacists' patient care process to contraceptive prescribing. Pharmacy. 2020;8(3):146. Available at: https://www.mdpi.com/2226-4787/8/3/146
Lynch SE, Griffin BL, Vest KM. Assessment of a simulated contraceptive prescribing activity for pharmacy students. Curr Pharm Teach Learn. 2018;10(2):178-184. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29706273
Nguyen M, O'Grady NO, Rafie S, Mody S, Hildebrand M. Direct pharmacist prescribing of emergency contraception: Findings of an academic detailing intervention. J Contemp Pharm Pract 2021;68(3):14-7. Available at: https://meridian.allenpress.com/jcphp/article/68/3/14/473049/Direct-Pharmacist-Prescribing-of-Emergency
Rafie S, El-Ibiary SY. Student pharmacist perspectives on providing pharmacy-access hormonal contraception services. J Am Pharm Assoc 2011;51(6):762-5. Available at: https://pubmed.ncbi.nlm.nih.gov/22068199/
Rim C, El-Ibiary SY, Rafie S, Borgelt LM. Assessment of contraceptive curricula in US pharmacy programs. Curr Pharm Teach Learn. 2020;12(4):395-9. Available at: https://pubmed.ncbi.nlm.nih.gov/32334754/
Stone RH, Cieri-Hutcherson NE, Vernon V, et al. Curricular Considerations for Preparing Student Pharmacists to Prescribe Hormonal Contraception. Am J Pharm Educ. 2022; Available at: https://pubmed.ncbi.nlm.nih.gov/34385172/
Stone RH, Rafie S, Griffin B, Shealy K, Stein AB. Pharmacist self-perception of readiness to prescribe hormonal contraception and additional training needs. Curr Pharm Teach Learn 2020;12(1):27-34. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31843161
Ahmad ZM, Noel NL, Rudd TM, et al. Implementation of a pharmacist-led hormonal contraceptive prescribing service in a campus community pharmacy in Indiana, United States. Contraception. 2022.Epub; Available at: https://pubmed.ncbi.nlm.nih.gov/35577148/
Batra P, Rafie S, Zhang Z, et al. An evaluation of the implementation of pharmacist-prescribed hormonal contraceptives in California. Obstet Gynecol 2018;131(5):850-5. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29630024
Beal JL, Bentley JP, Snyder ME, Zillich AJ, Rafie S, Illingworth Plake KS. Impact of pharmacist prescribing through direct pharmacy access policies on access to hormonal contraception. J Am Pharm Assoc. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34454867/
Bustin DJ, Simmons R, Galdo J, Kucek ME, Logan L, Cohn R, Smith H. Feasibility of a contraceptive-specific electronic health record system to promote the adoption of pharmacist-prescribed contraceptive services in community pharmacies in the United States. Journal of the American Medical Informatics Association. 2024;7(3):1-11. Available at: https://pubmed.ncbi.nlm.nih.gov/39040536/
Campi JA, Rafie S, Newlon JL, Meredith AH. Implementation of pharmacist-prescribed contraceptive services: A case series of early adopters. Journal of the American Pharmacists Association Practice Innovations. 2024;1. Available at: https://pubmed.ncbi.nlm.nih.gov/39420991/
Chen L, Lim J, Jeong A, Apollonio DE. Implementation of hormonal contraceptive furnishing in San Francisco pharmacies. J Am Pharm Assoc. 2020;60(6):963-8. Available at: https://pubmed.ncbi.nlm.nih.gov/32800456/
Collins-Doijode H, Oehlers J, et al. Availability of Pharmacist-Prescribed Contraception in Hawai'i. Hawaii J Health Soc Welf. 2022; Available at: https://pubmed.ncbi.nlm.nih.gov/35923386/
Dale LE, Trujillo V, Herman A, Sussman AL, Espey E, Hofler LG. Implementation of pharmacy access to hormonal contraception. Journal of the American Pharmacists Association. 2024;64(1):235-244. Available at: https://www.japha.org/article/S1544-3191(23)00348-5/fulltext
Frost TP, Klepser DG, Small DC, Doyle IC. Time and motion study of pharmacist prescribing of oral hormonal contraceptives in Oregon community pharmacies. J Am Pharm Assoc. 2019 https://www.ncbi.nlm.nih.gov/pubmed/30745187
Gardner JS, Miller L, Downing DF, Le S, Blough D, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J Am Pharm Assoc. 2008;48(2):212-21; 5 p following 221. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18359734
Gomez AM. Availability of Pharmacist-Prescribed Contraception in California, 2017. JAMA 2017;318(22):2253-2254. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29234797
Gomez AM, McCullough C, Hoff C. Expectations of future provision of pharmacist-prescribed hormonal contraception in California. Am J Obstet Gynecol . 2018;218(6):627-8. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29474845
Gomez AM, McCullough C, Fadda R, et al. Facilitators and barriers to implementing pharmacist prescribed hormonal contraception in California independent pharmacies. Women Health. 2020;60(3):249-9. Available at: https://pubmed.ncbi.nlm.nih.gov/31264530/
Grant A, Trenaman S, Stewart S, Liu L, Fisher J, Jeffers E, Lawrence R, Murphy A, et al. Uptake of community pharmacist prescribing over a three-year period. Exploratory Research in Clinical and Social Pharmacy. 2023;9. Available at: https://pubmed.ncbi.nlm.nih.gov/36703714/
Jacobsohn T, Nguyen BT, Brown JE, et al. Male contraception is coming: Who do men want to prescribe their birth control? Contraception. 2022; Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/35550379/
Lahrman R, Shin YE, Porter B, Beatty S, Hincapie AL. Pharmacists’ facilitators and barriers to implementing and billing for patient care services: Interviews from the Ohio Medicaid Project. Journal of the American Pharmacists Association. 2023;63:1077-1086. Available at: https://www.japha.org/article/S1544-3191(23)00090-0/fulltext
Lu S, Rafie S, Jamper J, Strauss R, Kroon L. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies. Contraception. 2018. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30562478
Magnusson BM, Christensen SR, Tanner AB, Eyring JB, Pilling EB, Sloan-Aagard CD. Accessibility of Pharmacist-Prescribed Contraceptives in Utah. Obstet Gynecol 2021;138(6):871-877. Available at: https://pubmed.ncbi.nlm.nih.gov/34735383/
Meredith AH, Wilkinson TA, Campi JA, et al. Use of the Delphi method to enhance pharmacist contraceptive counseling materials. J Pharm Pract. 2019;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/31868076/
Mody SK, Rafie S, Hildebrand M, Oakley LP. Exploring emergency contraception prescribing by pharmacists in California. Contraception 2019. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31493380
Navarrete J, Hughes CA, Yuksel N, et al. Community pharmacists' provision of sexual and reproductive health services: A cross-sectional study in Alberta, Canada. J Am Pharm Assoc. 2022; Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/35153160/
Newlon JL, Campi JA, Rafie S, Meredith AH. Determining user implementation needs for pharmacist-prescribed contraception using concept mapping: A participatory, multiple stakeholder approach. Exploratory Research in Clinical and Social Pharmacy. 2024;16:1-7. Available at: https://www.sciencedirect.com/science/article/pii/S2667276624001227
Newlon JL, Bentley JP, Snyder ME, Zillich AJ, Rafie S, Illingworth Plake KS. Impact of pharmacist prescribing through direct pharmacy access policies on access to hormonal contraception. J Am Pharm Assoc. 2022; Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34454867/
Qato DM, Alexander GC, Guadamuz JS, Trotzky-Sirr R, Lindau ST. Pharmacist-prescribed and over-the-counter hormonal contraception in Los Angeles County retail pharmacies. Health Aff 2020;39(7):1219-28. Available at: https://pubmed.ncbi.nlm.nih.gov/32634349/
Rafie S, Wollum A, Grindlay K. Patient experiences with pharmacist prescribed hormonal contraception in California independent and chain pharmacies. J Am Pharm Assoc. 2022;62(1):378-386. Available at: https://pubmed.ncbi.nlm.nih.gov/34996577/
Rashid ZH, O’Connell MB, Yang K. Implementation science to analyze motivators and barriers to pharmacist-prescribed contraception in Michigan community pharmacies. Journal of the American College of Clinical Pharmacy. 2022;5:1253-1262. Available at: https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/jac5.1730
Rodriguez MI, Anderson L, Edelman AB. Pharmacists begin prescribing hormonal contraception in Oregon: Implementation of House Bill 2879. Obstet Gynecol. 2016;128(1):168-70. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917426/
Rodriguez MI, Biel FM, Swartz JJ, Anderson L, Edelman AB. Pharmacists’ experience with prescribing hormonal contraception in Oregon. J Am Pharm Assoc 2018;58(6):608-613. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30190201
Rodriguez MI, Edelman AB, Skye M, Anderson A, Darney BG. Association of pharmacist prescription with dispensed duration of hormonal contraception. JAMA Netw Open 2020;3(5):e205252. Available at: https://pubmed.ncbi.nlm.nih.gov/32432710
Rodriguez MI, Edelman AB, Skye M, Darney BD. Reasons for and experience in obtaining pharmacist prescribed contraception. Contraception 2020;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/32502494/
Rodriguez MI, Garg B, Williams SM, Souphanavong J, Schrote K, Darney BG. Availability of pharmacist prescription of contraception in rural areas of Oregon and New Mexico. Contraception 2020;101:210-2. Available at: https://pubmed.ncbi.nlm.nih.gov/31862410/
Siddiqui N, Rafie S, Bull ST, Mody SK. Access to contraception in pharmacies during the COVID-19 pandemic. J Am Pharm Assoc. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34452840/
Simmons RG, Baayd J, Tak C, Turok DK, Elliott S, Smith JD. A stakeholder-developed logic model to improve utilization of pharmacy-prescribed contraception in Utah. Implementation Science Communications. 2023;124(4). Available at: https://implementationsciencecomms.biomedcentral.com/articles/10.1186/s43058-023-00503-6
Stone RH, Rafie S, Ernest D, Scutt B. Emergency contraception access and counseling in urban pharmacies: a comparison between states with and without pharmacist prescribing. Pharmacy. 2020;8(2):105. Available at: https://www.mdpi.com/2226-4787/8/2/105
Walsh S, Irwin AN, Anderson L, Zehrung C. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879. J Am Pharm Assoc 2019;59(4S):S112-6. Available at: https://pubmed.ncbi.nlm.nih.gov/31010785
Wilkinson TA, Meredith AH, Rafie S, et al. Adolescents’ and young adults’ ability to self-screen for contraindications to hormonal contraception and the role of chronic illness. J Adolesc Health. 2021;69(4):566-573. Available at: https://pubmed.ncbi.nlm.nih.gov/34092474/
Wilkinson TA, Rafie S, Clark PD, Carroll AE, Miller E. Evaluating community pharmacy responses about levonorgestrel emergency contraception by mystery caller characteristics. J Adolesc Health 2018;63(1):32-36. Available at: https://www.ncbi.nlm.nih.gov/pubmed/29475729
Adgalanis MA, Davis BT, Hettinger KN, Thoma LM, Papineau JH, Meredith AH. Pharmacist-led hormonal contraceptive prescribing service in a Federally Qualified Health Center: Initial implementation outcomes. Journal of the American Pharmacists Association. 2023;63:1185+1190. Available at: https://pubmed.ncbi.nlm.nih.gov/37146941/
Anderson L, Hartung DM, Middleton L, Rodriguez MI. Pharmacist provision of hormonal contraception in the Oregon Medicaid population. Obstet Gynecol 2019;133(6):1231-7. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31135739
Gibbs SE, Harvey SM. Pharmacist prescription and acces to hormonal contraception for Medicaid-insured women in Oregon. Contraception. 2020;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/32652093/
Grossman D, Ray A, Wadsworth A. The pharmacist will see you now: Pharmacist prescribed contraceptives and fertility rates. Journal of Health Economics. 2025;100:1-21. Available at: https://www.sciencedirect.com/science/article/pii/S0167629624000870
Pelaccio K, Bright D, Dillaway H, O’Connell MB. Birth control use and access including pharmacist-prescribed contraception services during COVID-19. Pharmacy. 2022;10(142):1-12. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9680515/
Rodriguez MI, Darney BG, Edelman AB, Yee K, Anderson LB, McConnell KJ. Pharmacists expand access to reproductive healthcare: PEARL study protocol. BMC Health Serv Res 2019;19(1):207. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30935394
Rodriguez MI, Hersh A, Anderson LB, Hartung DM, Edelman AB. Association of pharmacist prescription of hormonal contraception with unintended pregnancies and Medicaid costs. Obstet Gynecol 2019;133(6):1238-46. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31135740
Rodriguez MI, Kaufman M, Manibusan B, Anderson L, McConnell KJ. Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist. Contraception. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34116068/
Rodriguez M, Manibusan B, Kaufman M, et al. Association of pharmacist prescription of contraception with breaks in coverage. Obstetrics & Gynecology. 2022; 139(5):781-787. Available at: https://pubmed.ncbi.nlm.nih.gov/35576337/
Rodriquez MI, Skye M, Edelman AB, Anderson L, Darney BG. Association of pharmacist prescription and 12-month contraceptive continuation rates. Am J Obstet Gynecol. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34217725/
Ashcraft AM, Ponte CD, Farjo S, Dotson S, Murray PJ. The [underutilized] power of independent pharmacies to promote public health in rural communities: A call to action. J Am Pharm Assoc. 2022; Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34556429/
Beal JL, Illingworth Plake KS. Social and legislative shaping of access to contraceptives and the pharmacist's role: A literature review. Res Social Adm Pharm. 2020;16(5):628-636. Available at: https://pubmed.ncbi.nlm.nih.gov/31337541/
Buckingham P, Amos N, Hussainy SY, Mazza D. Scoping review of pharmacy-based initiatives for preventing unintended pregnancy: protocol. BMJ Open. 2020;10(1). Available at: https://www.ncbi.nlm.nih.gov/pubmed/32014873
Downing D. Inviting the pharmacist: a model for improved reproductive care access. Contraception 2012;85(1):2-4. Available at: https://www.ncbi.nlm.nih.gov/pubmed/22070991
Eckhaus LM, Ti AJ, Curtis KM, et al. Patient and pharmacist perspectives on pharmacist-prescribed contraception: A systematic review. Contraception 2021;103(2):66-74. Available at: https://pubmed.ncbi.nlm.nih.gov/33130109/
Farris KB, Ashwood D, McIntosh J, DiPietro NA, Maderas NM, Landau SC, Swegle J, Solemani O. Preventing unintended pregnancy: pharmacists' roles in practice and policy via partnerships. J Am Pharm Assoc 2010;50(5):604-12. Available at: https://www.ncbi.nlm.nih.gov/pubmed/20833619
Gaffield ME, Kiarie J, Narasimhan ML. Should oral contraceptive pills be available without a prescription? A systematic review of over-the-counter and pharmacy access availability. BMJ Glob Health. 2019;4(3):e001402. Available at: https://pubmed.ncbi.nlm.nih.gov/31321085/
Kooner M, Joseph H, Griffin B, Lynch S, Vest K, Stewart-Lynch A, Weaver K. Hormonal contraception prescribing by pharmacists: 2019 update. J Am Pharm Assoc. 2020;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/32144081/
Levin A, Berger K. Call to action: The pharmacist's role in improving contraceptive knowledge and access. J Am Pharm Assoc. 2022. Available at: https://pubmed.ncbi.nlm.nih.gov/36163126/
Maderas NM, Landau SC, Taylor-McGhee B. The continuum of care: a case for pharmacists as key members of the reproductive health care team. Contraception 2008;77(3):139-42. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18279681
Mitchell M, Stauffenberg C, Vernon V, Mospan CM, Shipman AJ, Rafie S. Opposition to pharmacist contraception services: Evidence for rebuttal. Pharmacy 2020;Epub. Available at: https://www.mdpi.com/2226-4787/8/4/176
Mospan CM. Pharmacists as contraceptive providers: Missed opportunities to enhance public persona. J Am Pharm Assoc. 2018;58(4):370. Available at: https://pubmed.ncbi.nlm.nih.gov/29735388/
Mospan CM. Pharmacists as women's health providers: Increasing access to contraception and preconception care. J Am Pharm Assoc 2019;59(5):613-4. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31422025
Mospan C, Vernon V, Rafie S. Pharmacist contraception services: All about access. J Am Pharm Assoc 2022;62(1):345-8. Available at: https://pubmed.ncbi.nlm.nih.gov/34920956/
Navarrete J, Yuksel N, Schindel TJ, Hughes C. Sexual and reproductive health services provided by community pharmacists: a scoping review. BMJ Open. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34312200/
Pfaff A, Rafie S. Expanding pharmacy capacity for patient-centered reproductive health services. Pharmacy. 2020;8(4):236. Available at: https://pubmed.ncbi.nlm.nih.gov/33316908/
Rafie S, Landau S. Opening New Doors to Birth Control: State Efforts to Expand Access to Contraception in Community Pharmacies. Birth Control Pharmacist, 2019. Available at: https://birthcontrolpharmacist.com/report.
Smith MC, Wetherbee H, Sharpe TR. The pharmacist and family planning: review and report of a study. Am J Pharm. 1978;150(5):152-9. Available at: https://pubmed.ncbi.nlm.nih.gov/12260649/
Soon JA, Whelan AM, Yuksel N, Rafie S. Enhancing access to contraception through pharmacist prescribing across Canada. Canadian Pharmacists Journal. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34777642/
Stone RH, Cieri-Hutcherson NE, Vernon V, et al. An integrative review of curricular considerations for preparing student pharmacists to prescribe hormonal contraception. Am J Pharm Educ. 2021;Epub. Available at: https://pubmed.ncbi.nlm.nih.gov/34385172/
Tak CR, Kessler LT, Scott MA, et al. Contraceptive prescribing: Professional standards and legal protections for the pharmacist. J Am Pharm Assoc. 2020;60(2):293-4. Available at: https://pubmed.ncbi.nlm.nih.gov/32144080/
Tak CR, Kessler LT, Scott MA, Gunning KM. Pharmacist-prescribed hormonal contraception: A review of the current landscape. J Am Pharm Assoc 2019;59(5):633-41. Available at: https://www.ncbi.nlm.nih.gov/pubmed/31300307
Williams RL, Meredith AH, Ott MA. Expanding adolescent access to hormonal contraception: an update on over-the-counter, pharmacist prescribing, and web-based telehealth approaches. 2018. Curr Opin Obstet Gynecol. 2018;30(6):458-464. Available at: https://www.ncbi.nlm.nih.gov/pubmed/30299318
Yang YT, Kozhimannil KB, Snowden JM. Pharmacist-Prescribed Birth Control in Oregon and Other States. JAMA. 2016;315(15):1567–1568. Available at: https://www.ncbi.nlm.nih.gov/pubmed/27019133
Last updated January 16, 2025